- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
GlaxoSmithKline Pharmaceuticals Limited — Updates, 09-02-2026: Press Release
09-02-2026 | 03:44 pm
09-02-2026 | 03:44 pm
GSK India's Q3 revenue crossed 1000 Cr (+8.1%), reaching 1023 Cr, with PAT at 277 Cr and EBIDTA margins up 520bps to 35.9%. Growth was driven by strong performance in General Medicines, Vaccines, and the new, gaining-traction Oncology business.
No comments yet. Be the first to comment!
All announcements from GlaxoSmithKline Pharmaceuticals Limited